TPCW
GMED icon

TD Private Client Wealth’s Globus Medical GMED Stock Holding History

TD Private Client Wealth’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4
Closed -$345 – 1729
2026
Q1 		$345 Buy
4
+2
+100% +$180 ﹤0.01% 1518
2025
Q4 		$175 Buy
+2
New +$152 ﹤0.01% 1548
2025
Q3 		– Sell
-8
Closed -$472 – 1547
2025
Q2 		$472 Buy
+8
New +$517 ﹤0.01% 1350
2024
Q2 		– Sell
-123
Closed -$6.6K – 1230
2024
Q1 		$6.6K Sell
123
-273
-69% -$14.7K ﹤0.01% 1078
2023
Q4 		$21.1K Buy
396
+114
+40% +$5.56K ﹤0.01% 947
2023
Q3 		$14K Sell
282
-2,135
-88% -$119K ﹤0.01% 986
2023
Q2 		$144K Sell
2,417
-637
-21% -$36.3K 0.01% 606
2023
Q1 		$173K Sell
3,054
-29,671
-91% -$1.9M 0.01% 568
2022
Q4 		$2.43M Buy
32,725
+9,804
+43% +$668K 0.11% 183
2022
Q3 		$1.37M Sell
22,921
-344
-1% -$20.7K 0.07% 257
2022
Q2 		$1.31M Buy
23,265
+22,844
+5,426% +$1.5M 0.06% 276
2022
Q1 		$31.1K Buy
+421
New +$29.3K ﹤0.01% 865

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

TD Private Client Wealth's GMED Position: Q2 2026 in Review

TD Private Client Wealth sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 4 shares — an estimated $345 sold.

TD Private Client Wealth first reported a position in GMED in Q1 2022 and held it in 12 quarters. The position peaked at $2.43M in Q4 2022. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • TD Private Client Wealth reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • TD Private Client Wealth sold 4 Globus Medical shares in Q2 2026, an estimated $345.
  • TD Private Client Wealth first reported a position in Globus Medical in Q1 2022 and held it in 12 quarters.
  • TD Private Client Wealth's Globus Medical position peaked at $2.43M in Q4 2022.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.